| Unbound MEDLINE results for: | Bookmark this site | | Articles related to 10999842 [Unique ID], provided by the PubMed system | |
| |
|
| | 1 - 10 of 215 journal articles in the PubMed database | Email to a friend | | |
| Maheshwari HG, Prezant TR, Herman-Bonert V, et al.
Long-acting peptidomimergic control of gigantism caused by pituitary acidophilic stem cell adenoma. [Case Reports, Journal Article]
J Clin Endocrinol Metab 2000 Sep; 85(9):3409-16.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Ferone D, Pivonello R, Lastoria S, et al.
In vivo and in vitro effects of octreotide, quinagolide and cabergoline in four hyperprolactinaemic acromegalics: correlation with somatostatin and dopamine D2 receptor scintigraphy. [Case Reports, Journal Article]
Clin Endocrinol (Oxf) 2001 Apr; 54(4):469-77.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Schoof E, Dörr HG, Kiess W, et al.
Five-year follow-up of a 13-year-old boy with a pituitary adenoma causing gigantism--effect of octreotide therapy. [Case Reports, Journal Article]
Horm Res 2004; 61(4):184-9.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Resmini E, Dadati P, Ravetti JL, et al.
Rapid pituitary tumor shrinkage with dissociation between anti-proliferative and anti-secretory effects of a long-acting octreotide in an acromegalic patient. [JOURNAL ARTICLE]
J Clin Endocrinol Metab 2007 Feb 20.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Colao A, Ferone D, Marzullo P, et al.
Long-term effects of depot long-acting somatostatin analog octreotide on hormone levels and tumor mass in acromegaly. [Journal Article]
J Clin Endocrinol Metab 2001 Jun; 86(6):2779-86.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Góth M, Hubina E, Kovács L, et al.
[Novel pharmacologic therapies in acromegaly] [Journal Article, Review]
Orv Hetil 2002 May 12; 143(19 Suppl):1057-62.
Abstract | Full Citation | Find Related Articles | | Müssig K, Gallwitz B, Honegger J, et al.
Pegvisomant Treatment in Gigantism Caused by a Growth Hormone-secreting Giant Pituitary Adenoma. [Journal Article]
Exp Clin Endocrinol Diabetes 2007 Mar; 115(3):198-202.
Abstract | Full Citation | Find Related Articles | | Saveanu A, Gunz G, Guillen S, et al.
Somatostatin and Dopamine-Somatostatin Multiple Ligands Directed towards Somatostatin and Dopamine Receptors in Pituitary Adenomas. [Journal Article]
Neuroendocrinology 2006; 83(3-4):258-63.
Abstract | Full Citation | Find Related Articles | | Tajima T, Tsubaki J, Ishizu K, et al.
Case Study of a 15-Year-old Boy with McCune-Albright Syndrome Combined with Pituitary Gigantism: Effect of Octreotide-long Acting Release (LAR) and Cabergoline Therapy. [JOURNAL ARTICLE]
Endocr J 2008 Apr 30.
Abstract | Full Citation |   |
|
| |
Advertise on this site.
|
